NCT03869047View on ClinicalTrials.gov

Dexmedetomidine Added to Bupivacaine Versus Bupivacaine inTransincisionalU/S Guided Quadratus Lumborum Block in Open Renal Surgeries , A New Technique

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

August 1, 2019

Study Completion Date

August 15, 2019

Conditions
Anesthesia
Interventions
DRUG

Dexmedetomidine +bupivacaine

patients will receive combined general anesthesia and Quadratuslumborum block( transincisional ie before wound closure)with 19 mL of bupivacaine 0.20%plus 1 mic/kg of dexmedetomidine, total volume 20 ml

DRUG

Bupivacaine

patients will receive combined general anesthesia and quadratus lumborum block (transincisional) with 20 ml of bupivacaine 0.20% .

Trial Locations (1)

Unknown

Ain Shams University hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03869047 - Dexmedetomidine Added to Bupivacaine Versus Bupivacaine inTransincisionalU/S Guided Quadratus Lumborum Block in Open Renal Surgeries , A New Technique | Biotech Hunter | Biotech Hunter